The type 2 asthma mediator IL-13 inhibits SARS-CoV-2 infection of bronchial epithelium
L. R. Bonser, W. L. Eckalbar, L. Rodriguez, J. Shen, K. D. Koh, L. T. Zlock, S. Christenson, P. G. Woodruff, W. E. Finkbeiner, D. J. Erle
This study shows IL-13 reduces SARS-CoV-2 infection in bronchial epithelial cells by altering gene expression and inhibiting viral replication.
bioRxiv · Feb 25, 2021Cell Biology